{"nct_id":"NCT03547154","title":"Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)","status":"TERMINATED","status_verified_date":"2019-07","start_date":"1998-10-22","start_date_type":"ACTUAL","primary_completion_date":"2001-02-20","primary_completion_date_type":"ACTUAL","completion_date":"2001-02-20","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["MRK"]}